Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
ImmunoGen Appoints Isabel Kalofonos as Senior Vice President and Chief Commercial Officer
ImmunoGen, a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of […]
Sitero Appoints Jeff Huntsman as Chief Commercial Officer
Sitero is pleased to announce the addition of Jeff Huntsman to its growing leadership team […]
Matthew Shaulis appointed Chief Commercial Officer and US President of Hansa Biopharma
Hansa Biopharma, a pioneer in enzyme technology for rare immunological conditions, announced today that Matthew […]
Scholar Rock Appoints Tracey M. Sacco as Chief Commercial Officer
Scholar Rock, a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious diseases […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more